Sodium Valproate Inquiry [2025]

Sodium Valproate Inquiry [2025] Coleman Legal LLP

The Sodium Valproate Inquiry in Ireland commenced on 22 July 2025, marking a major investigation into the drug’s historic use and its devastating impact on children exposed in the womb.

Failings at in maternity service cost the State 320m between 2015 and 2019

State Claims Agency review highlights failures in maternity care

A review by the State Claims Agency of maternity claims from 2015-2019 has revealed critical failures in fetal heart monitoring, CTG trace interpretation, and labour induction methods. Advocacy groups, including Safer Births Ireland, have called for an in-depth inquiry as concerns over maternity care persist,

Epilim Sodium Valproate Birth Defects

Epilim Sodium Valproate Birth Defects Coleman Legal LLP

Sodium Valproate birth defects can be devastating for families and may result in full-time care requirements. This epilepsy drug, commonly known as Epilim, has caused severe birth defects in thousands of children worldwide when taken during pregnancy, leading to conditions such as spina bifida, distinctive facial features, and developmental disorders as part of Foetal Valproate Syndrome.